Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshihiko Ishida

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 15, 2005
[Glucose and lipid metabolism by the liver]Toshihiko Ishida
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|February 20, 2007
[Hypertension complicated with diabetes mellitus]Toshihiko Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 22, 2010
[Islet cell antibody (ICA), islet cell surface antibody (ICSA)]Toshihiko Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 23, 2005
[Review of exercise in prevention of diabetes]Toshihiko Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 10, 2005
[Islet cell antibody (ICA), islet cell surface antibody (ICSA)]Toshihiko Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 5, 2005
[Fructosamine]Toshihiko Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 15, 2002
[Acute complications due to diabetes mellitus: Hyperosmolar nonketotic coma]Koichi Kawanishi, Toshihiko Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 7, 2006
[Ectopic insulin secretion]Toshihiko Ishida, Koji Murao
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 15, 2002
[Acute complications due to diabetes mellitus: Lactic acidosis]Koichi Kawanishi, Toshihiko Ishida
Diabetes & Vascular Disease Research|June 22, 2012
The combination of OLmesartan and a CAlcium channel blocker (azelnidipine) or candesartan and a calcium channel blocker (amlodipine) in type 2 diabetic hypertensive patients: the OLCA studyHiroyuki Daikuhara, Fumi Kikuchi, Toshihiko Ishida
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 15, 2005
[Glucose and lipid metabolism by the liver]Toshihiko Ishida
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|February 20, 2007
[Hypertension complicated with diabetes mellitus]Toshihiko Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 22, 2010
[Islet cell antibody (ICA), islet cell surface antibody (ICSA)]Toshihiko Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 23, 2005
[Review of exercise in prevention of diabetes]Toshihiko Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 10, 2005
[Islet cell antibody (ICA), islet cell surface antibody (ICSA)]Toshihiko Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 5, 2005
[Fructosamine]Toshihiko Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 15, 2002
[Acute complications due to diabetes mellitus: Hyperosmolar nonketotic coma]Koichi Kawanishi, Toshihiko Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 7, 2006
[Ectopic insulin secretion]Toshihiko Ishida, Koji Murao
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 15, 2002
[Acute complications due to diabetes mellitus: Lactic acidosis]Koichi Kawanishi, Toshihiko Ishida
Diabetes & Vascular Disease Research|June 22, 2012
The combination of OLmesartan and a CAlcium channel blocker (azelnidipine) or candesartan and a calcium channel blocker (amlodipine) in type 2 diabetic hypertensive patients: the OLCA studyHiroyuki Daikuhara, Fumi Kikuchi, Toshihiko Ishida
Pageof 15